Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Each of these biotech stocks has real potential to tackle other health-related issues, some of which have plagued us for centuries. 7 Retail Stocks That You Don't Want In Your Cart ...

Should Investors Be Watching these Top Biotech Stocks Right Now?As we approach the end of 2021, it seems that biotech stocks could continue to make viable plays in the stock market. This can be ...

The move higher in biotech stocks comes after a rough start in the first half of the year, when the biotech index lost 17.7%, more than it lost in the first six months of any year since 2016.

Small- and midcap biotech stocks are riskier, but have been hardest hit in the sector's decline. "Smid-cap biotech looks very cheap compared with historical levels," Yee said.